‘Personomics: Putting the Patient at the Centre of Prescribing and Medicines Use’

PRIMM (UK & Ireland) 33rd Annual Scientific Meeting

 We would like to thank evreyone for attending our 33rd annual scientific meeting on Personomics: Putting the Patient at the Centre of Prescribing and Medicines Use, in Manchester.

 We had excellent and thought provoking presentations around personalising care for the people we look after.  From a general view on the benefits of personalised care and issues people have with adherence (and why) from Alf and Rob to the demystifying the world of genomics by Vicky and Dyfrig. We finished with a fantastic presentation from Andrew who shared his experiences of using the NHS and medicines from being a child, with honesty, humility and some wonderful humour.

 We had excellent oral presentations and congratulations to Xinchun Gu from Manchester University for winning the best abstract prize; an excellent presentation on Investigating the Risk of Severe Adverse Events in people who take Gabapentinoids.  Our posters were, yet again of a fantastic standard with some excellent work covering diverse areas such as drug utilisation, clinical use of medicines, sustainability and safety. Congratulations to Yubo Wang and team from Manchester University for winning the best poster.  We have submitted all the abstracts to Pharmacoepidemiology and Drug Safety and will let you know when they are published.  A report of PRIMM22 will be available here soon.

Finally, we are delighted to announce our next scientific meeting on Friday 27th January 2023. The theme will be net zero and sustainability. We will be hosting this meeting online.  We will be back with a face to face meeting on Friday 26th January 2024 at a venue in an easy to reach city!  We will be publishing details on the 2023 symposium soon. As members, please feel free to suggest speakers (especially patient speakers), topic ideas and structure of the meeting on sustainability.

 With warmest regards,

 Waz and Sam

PRIMM Co-chairs, on behalf of the PRIMM committee

 Wasim.baqir@nhs.net

sam.sherrington@nhs.net

 

KEY NOTE SPEAKERS

Prof Robert Horne

Professor of Behavioural Medicine

Professor Robert Horne | UCL School of Pharmacy – UCL – University College London

Professor Rob Horne is Professor of Behavioural Medicine at the University College London (UCL) School of Pharmacy where he is Director of the Centre for Behavioural Medicine. In 2006, he joined the UCL School of Pharmacy where he established the Centre for Behavioural Medicine within the Research Department of Practice and Policy and was Head of Department between 2008 and 2012.

Following an initial decade in clinical pharmacy and medicines management within the NHS he completed a PhD in health psychology at Guys Medical School followed by a 17-year programme of research in behavioural medicine, focusing on the role of psychological and behavioural factors in explaining variation in response to treatment. His current interests centre on the development of interventions to support optimal engagement with essential treatments and effective medical innovations and on optimising the non-specific effects (placebo and nocebo components) of medicines.

 

Prof Dyfrig Hughes

Professor in Pharmacoeconomics

Prof Dyfrig Hughes | School of Medical and Health Sciences | Bangor University

Dyfrig Hughes graduated in pharmacy at Cardiff University before undertaking a PhD in cardiovascular pharmacology at the University of Liverpool (under the supervision of Dr Susan Coker). He subsequently trained in health economics (MSc, University of York), and was member of the Prescribing Research Group at the University of Liverpool (under the direction of Professor Tom Walley) until 2014.

Dyfrig is currently Professor of Pharmacoeconomics, co-director of the Centre for Health Economics and Medicines Evaluation at Bangor University and Director of Impact and Engagement. He is also academic lead for Pharmacy at the Betsi Cadwaladr University Health Board (covering North Wales), and is honorary professor at the Department of Molecular and Clinical Pharmacology, University of Liverpool.

                                Andrew Taylor

Patient Speaker

I was born with a congenital heart defect known as Tricuspid Atresia. Essentially, the right half of my heart was underdeveloped and therefore not working as it should. So, at an early age, I underwent open heart surgery to have an operation called a Classic Fontan procedure. I had a BT Shunt at age one to help the oxygenated blood move around my body but that was a quick fix, the Fontan was the main event. By bypassing the right side of my heart and connecting to the pulmonary I was given a unique circulatory system that has kept me alive and kicking for the last 30 years.

This is not to say that it has been smooth sailing. Over the years I have needed many medicines to help manage my condition and, unfortunately, many more medicines to counteract the side effects of the first medicines. From amiodarone to zoledronic acid I have been prescribed tablets, capsules, creams, paints and injections in order to remain in good health. Therefore, Pharmacy and my regular pharmacist have played more than a supporting role in the story of my life, they have been integral to me remaining in good health and enjoying a quality of life that everyone deserves to experience.

Prof Alf Collins

NHS England

Professor Alf Collins is NHS England’s Clinical Director, Personalised Care Group.

He was a community consultant in pain management and in parallel worked for a decade with the Health Foundation. He has researched and published widely on self-management support, shared decision making, care planning, co-production, patient activation and patient engagement.

He was honorary fellowships from the Royal College of Physicians and the Royal College of General Practitioners and is a Visiting Professor at Coventry University.

Victoria Chaplin

Vicky Chaplin

Pharmacy Genomics Lead

NHS England and NHS Improvement

Vicky is the Pharmacy Genomics Lead for the Genomics Unit at NHS England and NHS Improvement. She and her teamwork in collaboration with the NHS GMS Alliance Pharmacy Leads and other key stakeholders to embed genomic medicine into mainstream care, and enable patients to realise the benefits of medicines optimisation driven by genomic and diagnostic characterisation. This lead role is also part of the Chief Pharmaceutical Officer’s Pharmacy Advisory Group ensuring the work is coordinated across pharmacy and medicines developments across the NHS and government.

Since qualifying as a pharmacist, Vicky has worked across various sectors of pharmacy in the NHS, including primary care, secondary care and community pharmacy, as well as in regional and national roles supporting medicines optimisation and the use of medical devices, including digital therapeutics. She is a member of the Faculty of Clinical Informatics, holds an MSc in health economics and is qualified as an independent prescriber, for which she focused on her specialist clinical area of interest – diabetes. She has previously held roles as a Chief Pharmaceutical Officer’s Clinical Fellow and a NICE Medicines and Prescribing Associate. She has also worked as a Medical Advisor in the pharmaceutical industry.